Dopo DIECI anni dalla sua scoperta, il Terreno Oncologico continua a creare grandi preoccupazioni a untori, “Professori” e Editori di peer-reviews, per non parlare dei Membri della statunitense ASCO, che respingono come spasm le mie mail (V. Avanti) dopo la pessima figura che hanno fatto, ampiamente riferita in questo blog!
Nel corrente numero della BIBBIA della Medicina si legge un articolo firmato da u esercito di Autori, in cui si afferma che nel 15-30% dei casi nemmeno la biopsia con ago fine risolve la diagnosi dei nodi tiroidei.
Pensate al Terrorismo Psicologico Jatrogenetico – a cui il NEJM non è interessato e nemmeno ne parla – di chi, colpito da un nodo tiroideo, dopo una valanga di esami eseguiti in settimane e settimane, incluso l’esame istologico sul materiale ottenuto con il sottile ago …, si sente dire: “Bisogna intervenire chirurgicamente per sapere se lei ha un cancro”.
Medio Evo della Medicina, Serva dell’Economia: nessuna Autorità costituita – laica o religiosa che sia – parla di questa vergognosa situazione. Nemmeno il Ministro della Salute del Governo Monti, che dovrebbe aver sentito parlare di Terreno Oncologico e del dipendente Reale Rischio Congenito, diagnosticati con un fonendoscopio in un secondo e guaribili (SIC!).
Ecco di seguito il mio commento critico inviato a molti destinatari, che non cambierà assolutamente nulla. Tuttavia, incontrandomi e guradandomi negli occhi nessuna persona onesta potrà chiedermi: “Perché ti sei arreso?”
Original Message —–
From: Sergio Stagnaro
To: New Engl J Med ; giulia@veracyte.com ; ekalexander@partners.org
Cc: Pagliaro Prof Renato Scienza&Conosc ; La Piazzetta dei Medici ; Istituto Europ Oncol Sideri Mario ; JAMA ; Di Bella Prof. Giuseppe ; Lancet Editors ; Ann Int Med Editors ; BMC Editors ; SISBQ mailing list ; Frontiers in Endocrinology Editorial Office ; silvio.garattini@marionegri.it ; asco@asco.org
Sent: Wednesday, August 29, 2012 2:17 PM
Subject: Bedside Diagnosing Thyroid Cancer with QBS! NO interesting.
Dear NEJM Editors and paper Authors,
Firstly, I do not want, at all, losing my time in sending a Letter to NEJM Editors, who – as usually – will reject it, without reading it, answering a automatic response!
In the article “Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology. Erik K. Alexander, M.D., Giulia C. Kennedy, Ph.D., Zubair W. Baloch, M.D., et al. in Journal current issue, N Engl J Med 2012; 367:705-715August 23, 2012
I have distressingly read:
Approximately 15 to 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or malignant. Patients with cytologically indeterminate nodules are often referred for diagnostic surgery, though most of these nodules prove to be benign. A novel diagnostic test that measures the expression of 167 genes has shown promise in improving preoperative risk assessment.
Not to speak of Jatrogenetic Psychological Terrorism, no significant to you, brought about by the present Middle Ages of Medicine, overlooking Quantum Biophysical Semeiotics – QBS(1), I emphasise the urgent necessity to spread among physicians Oncological Terrain-Dependent-Inherited Real Risk, in our case of Thyroid Cancer, I have discovered 10 years ago (2-16), at the condition yiu want fefeat cancer, today’s growing epidemic.
Are you afraid, as italian competent Authority, italian “Professors”, and ASCO (I keep ASCO mail in a FILE!), too, about Oncological Terrain-Dependent-Inherited Real Risk of Malignancy?
In exactly one second, physicians skilled on QBS can either diagnose or exclude the presence of Thyroid Cancer Inherited Real Risk, and overt Cancer, of course!.
I ask you kindly not to invite me to send a Letter to Editor on this topic, since I admitt it’s no-politically correct.
Regards
Sergio Stagnaro
www.sisbq.org
www.semeioticabiofisica.it
References.
1) Stagnaro Sergio. Middle Ages of today’s Medicine, Overlooking Quantum-Biophysical-Semeiotic Constitutions and Related Inherited Real Risk. http://sciphu.com November 4, 2008. http://sciphu.com/2008/11/meadle-ages-of-todays-medicine.html
2) Stagnaro S., Stagnaro-Neri M., Le Costituzioni Semeiotico-Biofisiche.Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ediz. Travel Factory, Roma, 2004.
3) Stagnaro Sergio. Bed-Side Prostate Cancer Detecting, even in early stages (“Real Risk” of Cancer): BMC Family Practice, 6:24 doi:10.1186/1471-2296-6-24 http://www.biomedcentral.com/1471-2296/6/24/comments#20246
4) Sergio Stagnaro Mitochondrial Bed-Side Evaluation: a new Way in the War against Cancer (21 December 2005). Cancer Cell International http://www.cancerci.com/content/5/1/34/comments#218502
5) Stagnaro S. Genes and Cancer: a clinical view-point. The Oncological Terrain. BioMed Central Informatics, 2004. http://www.biomedcentral.com/1471-2105/5/21/comments#10454
6) Stagnaro S., Stagnaro-Neri M., Oncological Terrain, conditio sine qua non of Oncogenesis, GUT, 2004. http://www.gutjnl.com/cgi/eletters?lookup=by_date&days=60
7) Stagnaro Sergio. “Genes, Oncological Terrain, and Breast Cancer”, World Journal of Surgical Oncology. 2005, http://www.wjso.com/content/3/1/45/comments#205475
8)Stagnaro Sergio. GPs , Biophysical Semeiotics, and bedside cancer diagnosis. 08 July 2007, International Seminar of Surgical Oncology, http://www.issoonline.com/content/4/1/11/comments#281539
9) Stagnaro Sergio. Overloking Oncological Terrain and oncological Real Risk, no paper is up-dated! 18 January 2008 Ann. Intern Med. http://www.annals.org/cgi/eletters/147/11/775
10) Stagnaro Sergio. Reale Rischio Semeiotico Biofisico. I Dispositivi Endoarteriolari di Blocco neoformati, patologici, tipo I, sottotipo a) oncologico, e b) aspecifico. Ediz. Travel Factory, www.travelfactory.it, Roma, 2009.
11) Caramel S., Stagnaro S. The role of mitochondria and mit-DNA in Oncogenesis.
Quantum Biosystems 2010, 2, 221-248, http://www.quantumbiosystems.org/admin/files/QBS%202(1)%20250-281.pdf
12) Stagnaro Sergio, Stagnaro-Neri Marina. Introduzione alla Semeiotica Biofisica. Il Terreno oncologico”. Travel Factory SRL., Roma, 2004.
13) Sergio Stagnaro. Rinaldi’s Sign in bedside Diagnosing Di Bella’s Oncological Terrain and overt Cancer, both solid and liquid. SISBQ, II Intern. Congres, Chiusi (Siena), 28-29 May, 2011. http://www.sisbq.org/proceedings-2.html
http://www.sisbq.org/uploads/5/6/8/7/5687930/rinaldisign_eng.pdf
14) Sergio Stagnaro. Malignancies and mitochondrial dysfunction. Journal Clinical Investigation, 2003, http://www.jci.org/eletters/view/17741#sec1
15) Sergio Stagnaro. A fundamental bias of the research: Overlooking Congenital Acidosic Enzyme-Metabolic Histangiopaty-Dependent Brain Inherited Real Risk. Journal of Neurology, Neurosurgery & Psychiatry with practical Neurology, 5 May, 2009. http://jnnp.bmj.com/content/80/11/1206/reply
And FINALLY the most fascinating paper on bedside diagnosing OT-IRR:
Simone Caramel and Sergio Stagnaro The role of glycocalyx in QBS diagnosis of Di Bella’s Oncological Terrain – http://www.sisbq.org/uploads/5/6/8/7/5687930/oncological_glycocalyx2011.pdf